Pediatric "STUMP" lesions: evaluation and management of difficult atypical Spitzoid lesions in children

J Am Acad Dermatol. 2011 Mar;64(3):559-72. doi: 10.1016/j.jaad.2009.12.063. Epub 2011 Jan 20.

Abstract

Spitz nevi represent a distinct type of melanocytic nevi more commonly seen in childhood. Although typically benign, a subset of Spitz lesions raise concern and create a diagnostic dilemma as a result of confusing histology that involves characteristics of classic Spitz nevi intermixed with features of cutaneous melanoma. Such atypical Spitz lesions, or Spitzoid tumors of uncertain malignant potential, are difficult to classify and their biologic potential is uncertain. Nonetheless, these are critical tasks for both prognosis and clinical management. New tools, such as immunohistochemical stains, comparative genomic hybridization, and fluorescence in situ hybridization, have been used to provide further insight into these controversial lesions and to aid in their evaluation. In this review, we present our experience managing 6 cases of Spitzoid tumor of uncertain malignant potential and discuss the potential use of various diagnostic modalities, including sentinel lymph node biopsy, immunostaining, and molecular analysis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Clinical Protocols
  • Comparative Genomic Hybridization
  • Diagnosis, Differential
  • Female
  • Genes, ras / genetics
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Ki-67 Antigen / analysis
  • Male
  • Melanoma / diagnosis*
  • Melanoma / pathology
  • Nevus, Epithelioid and Spindle Cell / diagnosis
  • Nevus, Epithelioid and Spindle Cell / pathology*
  • Nevus, Epithelioid and Spindle Cell / surgery
  • Prognosis
  • Proto-Oncogene Proteins B-raf / genetics
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Tumor Suppressor Protein p53 / analysis
  • Tumor Suppressor Protein p53 / genetics
  • gp100 Melanoma Antigen / analysis

Substances

  • Ki-67 Antigen
  • Tumor Suppressor Protein p53
  • gp100 Melanoma Antigen
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf